← Leaderboards
Lisa M. Shulman
University Of Maryland Baltimore
$7,402,169
Attributed
$11,594,857
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,594,857 · 9
By mechanism
R01$8,385,376 · 3
U01$2,528,910 · 1
U10$659,149 · 1
M01$21,422 · 4
Top collaborators
- Ann L Gruber-Baldini7 shared
- Deborah A Hall4 shared
- Camille C Dunn2 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Roger Keith Reeves$28,096,305
- Robert L. Rubinstein$9,869,532
- Ilene H Zuckerman$1,701,781
- Ann L Gruber-Baldini$6,169,630
Others in their field
Top investigators on “Disability”
- Judith S Hochman · New York University School Of Medicine$100,149,457
- David R. Weir · University Of Michigan At Ann Arbor$93,172,925
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Judith Kasper · Johns Hopkins University$76,745,128
- Marco Pahor · Wake Forest University Health Sciences$76,288,008
- Steven R Cummings · University Of California San Francisco$71,270,829
Research focus
DisabilityResearch PersonnelSamplingMental DepressionParkinson DiseaseAlzheimer&AposAwarenessParticipantCommunitiesUnited States National Institutes Of HealthEnrollmentDesignCognitionPatient Outcomes AssessmentsClinical TrialsSiteCognitiveClinical PracticeNeurodegenerative DisordersValidationBaseData ReportingChronicAdopted
Grant awards (33)
The Effectiveness of Cochlear Implants in Real-World Settings for Mild Cognitive Impairment and Dementia in Older Adults with Age-Related Hearing Loss$712,224
R01 · FY2025 · AG
Racial Disparities in Parkinson Disease- Clinical Phenotype, Management and Genetics$628,158
R01 · FY2025 · NS
The Effectiveness of Cochlear Implants in Real-World Settings for Mild Cognitive Impairment and Dementia in Older Adults with Age-Related Hearing Loss$783,083
R01 · FY2024 · AG
Racial Disparities in Parkinson Disease- Clinical Phenotype, Management and Genetics$609,313
R01 · FY2024 · NS
Racial Disparities in Parkinson Disease- Clinical Phenotype, Management and Genetics$633,283
R01 · FY2023 · NS
PROMIS Profile Measures in Older Adults - Identifying Cognitive Thresholds for Reliable and Valid Responses$386,194
R01 · FY2023 · AG
Racial Disparities in Parkinson Disease- Clinical Phenotype, Management and Genetics$738,845
R01 · FY2022 · NS
PROMIS Profile Measures in Older Adults - Identifying Cognitive Thresholds for Reliable and Valid Responses$618,757
R01 · FY2022 · AG
PROMIS Profile Measures in Older Adults - Identifying Cognitive Thresholds for Reliable and Valid Responses$711,094
R01 · FY2021 · AG
PROMIS Profile Measures in Older Adults - Identifying Cognitive Thresholds for Reliable and Valid Responses$711,094
R01 · FY2020 · AG
PROMIS Profile Measures in Older Adults - Identifying Cognitive Thresholds for Reliable and Valid Responses$386,159
R01 · FY2020 · AG
PROMIS Profile Measures in Older Adults - Identifying Cognitive Thresholds for Reliable and Valid Responses$711,366
R01 · FY2019 · AG
PROMIS Profile Measures in Older Adults - Identifying Cognitive Thresholds for Reliable and Valid Responses$755,806
R01 · FY2018 · AG
A Simple Neuroprotection Trial in Parkinson's Disease$49,975
U10 · FY2014 · NS · contact PI
A Simple Neuroprotection Trial in Parkinson's Disease$41,334
U10 · FY2013 · NS · contact PI
Development and Validation of a Self-Efficacy Item Bank$598,839
U01 · FY2012 · AR · contact PI
A Simple Neuroprotection Trial in Parkinson's Disease$50,539
U10 · FY2012 · NS · contact PI
Development and Validation of a Self-Efficacy Item Bank$623,839
U01 · FY2011 · AR · contact PI
A Simple Neuroprotection Trial in Parkinson's Disease$55,393
U10 · FY2011 · NS · contact PI
Development and Validation of a Self-Efficacy Item Bank$649,834
U01 · FY2010 · AR · contact PI
A Simple Neuroprotection Trial in Parkinson's Disease$65,307
U10 · FY2010 · NS · contact PI
Development and Validation of a Self-Efficacy Item Bank$656,398
U01 · FY2009 · AR · contact PI
A Simple Neuroprotection Trial in Parkinson's Disease$50,142
U10 · FY2009 · NS · contact PI
CLINICAL TRIAL: STUDY OF ANTIDEPRESSANTS IN PARKINSON'S DISEASE (SAD-PD)$7,878
M01 · FY2009 · RR · contact PI
A Simple Neuroprotection Trial in Parkinson's Disease$30,152
U10 · FY2008 · NS · contact PI
CLINICAL TRIAL: STUDY OF ANTIDEPRESSANTS IN PARKINSON'S DISEASE (SAD-PD)$5,539
M01 · FY2008 · RR · contact PI
Simple Neuroprotection Trial in Parkinson's Disease$49,005
U10 · FY2007 · NS · contact PI
STUDY OF ANTIDEPRESSANTS IN PARKINSON'S DISEASE (SAD-PD)$7,014
M01 · FY2007 · RR · contact PI
A Simple Neuroprotection Trial in Parkinson's Disease$9,700
U10 · FY2006 · NS · contact PI
STUDY OF ANTIDEPRESSANTS IN PARKINSON'S DIS$991
M01 · FY2006 · RR · contact PI
A Simple Neuroprotection Trial in Parkinson's Disease$36,032
U10 · FY2005 · NS
A Simple Neuroprotection Trial in Parkinson's Disease$112,422
U10 · FY2003 · NS
Simple Neuroprotection Trial in Parkinson's Disease$109,148
U10 · FY2002 · NS